← Open Payments lookup

GEORGE GABRIEL TOLDNESS: Open Payments

NPI 1720646045 · LAS VEGAS, NV. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$795 in 32 payments from 9 companies in 2025. Trend: 2023 $602 · 2024 $629 · 2025 $795

Food & beverage: $795
CompanyPaymentsAmount
AstraZeneca Pharmaceuticals LP8$272
GlaxoSmithKline, LLC.9$207
Amgen Inc.4$90
PFIZER INC.3$71
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)3$70
Novo Nordisk Inc2$36
ABBVIE INC.1$19
Phadia US Inc.1$17
Lilly USA, LLC1$14

Products named: TRELEGY ELLIPTA, FARXIGA, OTEZLA, CAPLYTA, AIRSUPRA, ELIQUIS, Rybelsus, PAXLOVID.

Industry payments across NV — which companies pay providers there.